CD86 Blocking Peptide for STJ500487 peptide (STJ503837)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 250-329 on human CD86 protein.
General Information
| Short Description | CD86 Blocking Peptide for STJ500487 is synthetically produced from the 250-329 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | CD86 |
| Gene ID | 942 |
| Uniprot ID | CD86_HUMAN |
| Immunogen | Synthetic peptide taken within amino acid region 250-329 on human CD86 protein. |
| Immunogen Region | 250-329 |
| Specificity | This blocking peptide is recommended for use in combination with CD86 antibody, STJ500487 |
Additional Info
| Tissue Specificity | Expressed by activated B-lymphocytes and monocytes. |
| Post Translational Modifications | Polyubiquitinated.which is promoted by MARCH8 and results in endocytosis and lysosomal degradation. |
| Function | Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Also involved in the regulation of B cells function, plays a role in regulating the level of IgG(1) produced. Upon CD40 engagement, activates NF-kappa-B signaling pathway via phospholipase C and protein kinase C activation. Isoform 2: Interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation. (Microbial infection) Acts as a receptor for adenovirus subgroup B. |
| Peptide Name | T-Lymphocyte Activation Antigen Cd86Activation B7-2 AntigenB70Bu63Ctla-4 Counter-Receptor B7.2Fun-1Cd Antigen Cd86 |
| Database Links | Reactome: R-HSA-1257604Reactome: R-HSA-2219530Reactome: R-HSA-389356Reactome: R-HSA-389357Reactome: R-HSA-389359Reactome: R-HSA-389513Reactome: R-HSA-6783783Reactome: R-HSA-6811558 |
| Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane Protein |
| Alternative Peptide Names | T-Lymphocyte Activation Antigen Cd86 proteinActivation B7-2 Antigen proteinB70 proteinBu63 proteinCtla-4 Counter-Receptor B7.2 proteinFun-1 proteinCd Antigen Cd86 proteinCD86 proteinCD28LG2 protein |
Information sourced from Uniprot.org